Exubera and Hyperhidrosis - a phase IV clinical study of FDA data

Summary:

Hyperhidrosis is reported as a side effect among people who take Exubera (insulin recombinant human), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Lantus, and have Diabetes.

The phase IV clinical study analyzes which people have Hyperhidrosis when taking Exubera. It is created by eHealthMe based on reports of 448 people who have side effects when taking Exubera from the FDA, and is updated regularly.

What is Exubera?

Exubera has active ingredients of insulin recombinant human. eHealthMe is studying from 448 Exubera users. Check the latest studies of Exubera.

What is Hyperhidrosis?

Hyperhidrosis (abnormally increased sweating) is found to be associated with 2,563 drugs and 3,541 conditions by eHealthMe. Check the latest studies of Hyperhidrosis.

On Feb, 24, 2026

448 people reported to have side effects when taking Exubera.
Among them, 11 people (2.46%) have Hyperhidrosis.

Among these 11 people:

How long have people been on Exubera when they have Hyperhidrosis? *

What is the gender of people who have Hyperhidrosis when taking Exubera? *

female: 45.45 %
male: 54.55 %

What is the age of people who have Hyperhidrosis when taking Exubera? *

What are other drugs people take besides Exubera? *

Lantus: 4 people, 36.36%
Novolog: 3 people, 27.27%
Symlin: 2 people, 18.18%
Simvastatin: 2 people, 18.18%
Isosorbide Mononitrate: 2 people, 18.18%
Novolog Mix 70/30: 1 person, 9.09%
Lisinopril: 1 person, 9.09%
Atenolol: 1 person, 9.09%

What are other side effects people have besides Hyperhidrosis? *

Dyspnea (difficult or laboured breathing): 5 people, 45.45%
Blood Glucose Increased: 5 people, 45.45%
Cough: 4 people, 36.36%
Chest Pain: 4 people, 36.36%
Blood Glucose Decreased: 4 people, 36.36%
Cardiac Disorder: 3 people, 27.27%
Dry Throat: 3 people, 27.27%
Headache (pain in head): 3 people, 27.27%
Diabetes Mellitus Inadequate Control: 3 people, 27.27%
Wheezing (a high-pitched whistling sound made while you breath): 3 people, 27.27%

What are the existing conditions these people have? *

Diabetes: 5 people, 45.45%
Type 2 Diabetes: 4 people, 36.36%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 2 people, 18.18%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Exubera and have Hyperhidrosis?

- Check whether Hyperhidrosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Exubera:

Exubera (448 reports)

Hyperhidrosis treatments and more:

Hyperhidrosis (147,206 reports)

Browse all side effects of Exubera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperhidrosis:

Hyperhidrosis (2,563 drugs)

Browse all the conditions that are associated with Hyperhidrosis:

Hyperhidrosis (3,541 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin recombinant human (the active ingredients of Exubera) and Exubera (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.